Is Bolt Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BOLT) stock is to Buy BOLT stock.
Out of 1 analyst, 0 (0%) are recommending BOLT as a Strong Buy, 1 (100%) are recommending BOLT as a Buy, 0 (0%) are recommending BOLT as a Hold, 0 (0%) are recommending BOLT as a Sell, and 0 (0%) are recommending BOLT as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year BOLT price target, the average BOLT price target is $8.00, with the highest BOLT stock price forecast at $8.00 and the lowest BOLT stock price forecast at $8.00.
The Wall Street analyst predicted that Bolt Biotherapeutics's share price could reach $8.00 by Mar 22, 2025. The average Bolt Biotherapeutics stock price prediction forecasts a potential upside of 589.66% from the current BOLT share price of $1.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.